rs58447305

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001079866.2(BCS1L):​c.628G>A​(p.Asp210Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 1,613,996 control chromosomes in the GnomAD database, including 1,415 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.056 ( 677 hom., cov: 32)
Exomes 𝑓: 0.0086 ( 738 hom. )

Consequence

BCS1L
NM_001079866.2 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 2.36
Variant links:
Genes affected
BCS1L (HGNC:1020): (BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone) This gene encodes a homolog of the S. cerevisiae bcs1 protein which is involved in the assembly of complex III of the mitochondrial respiratory chain. The encoded protein does not contain a mitochondrial targeting sequence but experimental studies confirm that it is imported into mitochondria. Mutations in this gene are associated with mitochondrial complex III deficiency and the GRACILE syndrome. Several alternatively spliced transcripts encoding two different isoforms have been described. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016899705).
BP6
Variant 2-218661926-G-A is Benign according to our data. Variant chr2-218661926-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 136502.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCS1LNM_001079866.2 linkc.628G>A p.Asp210Asn missense_variant Exon 4 of 8 ENST00000359273.8 NP_001073335.1 Q9Y276A0A024R445

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCS1LENST00000359273.8 linkc.628G>A p.Asp210Asn missense_variant Exon 4 of 8 1 NM_001079866.2 ENSP00000352219.3 Q9Y276

Frequencies

GnomAD3 genomes
AF:
0.0560
AC:
8519
AN:
152074
Hom.:
672
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.185
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0276
Gnomad ASJ
AF:
0.0156
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00849
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.00350
Gnomad OTH
AF:
0.0480
GnomAD3 exomes
AF:
0.0182
AC:
4579
AN:
251114
Hom.:
294
AF XY:
0.0146
AC XY:
1980
AN XY:
135786
show subpopulations
Gnomad AFR exome
AF:
0.195
Gnomad AMR exome
AF:
0.0150
Gnomad ASJ exome
AF:
0.0146
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00709
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00378
Gnomad OTH exome
AF:
0.0189
GnomAD4 exome
AF:
0.00864
AC:
12634
AN:
1461804
Hom.:
738
Cov.:
33
AF XY:
0.00811
AC XY:
5900
AN XY:
727196
show subpopulations
Gnomad4 AFR exome
AF:
0.200
Gnomad4 AMR exome
AF:
0.0156
Gnomad4 ASJ exome
AF:
0.0166
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00723
Gnomad4 FIN exome
AF:
0.000262
Gnomad4 NFE exome
AF:
0.00254
Gnomad4 OTH exome
AF:
0.0192
GnomAD4 genome
AF:
0.0562
AC:
8552
AN:
152192
Hom.:
677
Cov.:
32
AF XY:
0.0536
AC XY:
3989
AN XY:
74418
show subpopulations
Gnomad4 AFR
AF:
0.185
Gnomad4 AMR
AF:
0.0276
Gnomad4 ASJ
AF:
0.0156
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00891
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00350
Gnomad4 OTH
AF:
0.0480
Alfa
AF:
0.0107
Hom.:
144
Bravo
AF:
0.0641
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.182
AC:
803
ESP6500EA
AF:
0.00488
AC:
42
ExAC
AF:
0.0214
AC:
2603
Asia WGS
AF:
0.0160
AC:
57
AN:
3478
EpiCase
AF:
0.00551
EpiControl
AF:
0.00563

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 09, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 15, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

GRACILE syndrome Benign:3
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jun 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:2
Dec 09, 2011
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Asp210Asn in exon 5 of BCS1L: This variant is not expected to have clinical si gnificance because it has been identified in 23.75% (314/1322) of African chromo somes by the 1000 Genomes Project (Phase 3; dbSNP rs58447305). -

Mitochondrial complex III deficiency nuclear type 1 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jun 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Leigh syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Pili torti-deafness syndrome Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
21
DANN
Benign
0.93
DEOGEN2
Benign
0.13
.;T;T;T;T;T;T;T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.027
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.87
D;.;.;.;.;.;.;D
MetaRNN
Benign
0.0017
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.54
.;N;N;N;N;N;N;N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.73
N;N;N;N;N;N;N;N
REVEL
Uncertain
0.33
Sift
Benign
0.63
T;T;T;T;T;T;T;T
Sift4G
Benign
0.59
T;T;T;T;T;T;T;T
Polyphen
0.0020
.;B;B;B;B;B;B;B
Vest4
0.12, 0.13, 0.078, 0.077, 0.076
MPC
0.59
ClinPred
0.013
T
GERP RS
4.8
Varity_R
0.11
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs58447305; hg19: chr2-219526649; API